PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:ALPAT - FR0010785790 - Common Stock
8.82 EUR
+0.1 (+1.15%)
We assign a fundamental rating of 5 out of 10 to ALPAT. ALPAT was compared to 80 industry peers in the Biotechnology industry. While ALPAT is still in line with the averages on profitability rating, there are concerns on its financial health. ALPAT is evaluated to be cheap and growing strongly. This does not happen too often!
1. Profitability
1.1 Basic Checks
In the past year ALPAT was profitable.
ALPAT had a positive operating cash flow in the past year.
In multiple years ALPAT reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: ALPAT reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of 5.88%, ALPAT belongs to the top of the industry, outperforming 80.25% of the companies in the same industry.
ALPAT has a better Return On Equity (10.00%) than 81.48% of its industry peers.
With a decent Return On Invested Capital value of 1.38%, ALPAT is doing good in the industry, outperforming 75.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.88% | ||
| ROE | 10% | ||
| ROIC | 1.38% |
ROA(3y)1.25%
ROA(5y)-1.47%
ROE(3y)2.03%
ROE(5y)-3.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 48.78%, ALPAT belongs to the best of the industry, outperforming 95.06% of the companies in the same industry.
ALPAT's Operating Margin of 10.90% is amongst the best of the industry. ALPAT outperforms 81.48% of its industry peers.
ALPAT has a better Gross Margin (116.00%) than 100.00% of its industry peers.
In the last couple of years the Gross Margin of ALPAT has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.9% | ||
| PM (TTM) | 48.78% | ||
| GM | 116% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.17%
GM growth 5Y-4.76%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALPAT is destroying value.
ALPAT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALPAT has more shares outstanding
The debt/assets ratio for ALPAT has been reduced compared to a year ago.
2.2 Solvency
ALPAT has an Altman-Z score of 0.59. This is a bad value and indicates that ALPAT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.59, ALPAT is in line with its industry, outperforming 53.09% of the companies in the same industry.
ALPAT has a debt to FCF ratio of 1.64. This is a very positive value and a sign of high solvency as it would only need 1.64 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.64, ALPAT belongs to the top of the industry, outperforming 82.72% of the companies in the same industry.
A Debt/Equity ratio of 0.15 indicates that ALPAT is not too dependend on debt financing.
ALPAT's Debt to Equity ratio of 0.15 is in line compared to the rest of the industry. ALPAT outperforms 54.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.64 | ||
| Altman-Z | 0.59 |
ROIC/WACC0.2
WACC6.83%
2.3 Liquidity
A Current Ratio of 0.58 indicates that ALPAT may have some problems paying its short term obligations.
With a Current ratio value of 0.58, ALPAT is not doing good in the industry: 83.95% of the companies in the same industry are doing better.
A Quick Ratio of 0.31 indicates that ALPAT may have some problems paying its short term obligations.
ALPAT's Quick ratio of 0.31 is on the low side compared to the rest of the industry. ALPAT is outperformed by 92.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.58 | ||
| Quick Ratio | 0.31 |
3. Growth
3.1 Past
ALPAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1100.00%, which is quite impressive.
Looking at the last year, ALPAT shows a quite strong growth in Revenue. The Revenue has grown by 14.61% in the last year.
The Revenue has been growing by 10.44% on average over the past years. This is quite good.
EPS 1Y (TTM)1100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.59%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y-5.79%
Revenue growth 5Y10.44%
Sales Q2Q%-43.46%
3.2 Future
The Earnings Per Share is expected to grow by 68.40% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALPAT will show a very strong growth in Revenue. The Revenue will grow by 31.88% on average per year.
EPS Next Y97.01%
EPS Next 2Y68.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.04%
Revenue Next 2Y31.88%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.50 indicates a reasonable valuation of ALPAT.
Based on the Price/Earnings ratio, ALPAT is valued cheaply inside the industry as 93.83% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.31. ALPAT is valued rather cheaply when compared to this.
The Forward Price/Earnings Ratio is negative for ALPAT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.5 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ALPAT is valued a bit cheaper than 77.78% of the companies in the same industry.
96.30% of the companies in the same industry are more expensive than ALPAT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.73 | ||
| EV/EBITDA | 16.67 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of ALPAT may justify a higher PE ratio.
ALPAT's earnings are expected to grow with 68.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.11
PEG (5Y)N/A
EPS Next 2Y68.4%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for ALPAT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:ALPAT (11/28/2025, 7:00:00 PM)
8.82
+0.1 (+1.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners33.62%
Ins Owner ChangeN/A
Market Cap9.88M
Revenue(TTM)1.93M
Net Income(TTM)940.00K
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.5 | ||
| Fwd PE | N/A | ||
| P/S | 5.13 | ||
| P/FCF | 4.73 | ||
| P/OCF | 3.95 | ||
| P/B | 1.05 | ||
| P/tB | 1.71 | ||
| EV/EBITDA | 16.67 |
EPS(TTM)0.84
EY9.52%
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)1.87
FCFY21.16%
OCF(TTM)2.23
OCFY25.31%
SpS1.72
BVpS8.39
TBVpS5.14
PEG (NY)0.11
PEG (5Y)N/A
Graham Number12.59
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.88% | ||
| ROE | 10% | ||
| ROCE | 1.92% | ||
| ROIC | 1.38% | ||
| ROICexc | 1.38% | ||
| ROICexgc | 2.05% | ||
| OM | 10.9% | ||
| PM (TTM) | 48.78% | ||
| GM | 116% | ||
| FCFM | 108.45% |
ROA(3y)1.25%
ROA(5y)-1.47%
ROE(3y)2.03%
ROE(5y)-3.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.17%
GM growth 5Y-4.76%
F-Score6
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.64 | ||
| Debt/EBITDA | 1.86 | ||
| Cap/Depr | 73.21% | ||
| Cap/Sales | 21.27% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 324.68% | ||
| Profit Quality | 222.34% | ||
| Current Ratio | 0.58 | ||
| Quick Ratio | 0.31 | ||
| Altman-Z | 0.59 |
F-Score6
WACC6.83%
ROIC/WACC0.2
Cap/Depr(3y)108.69%
Cap/Depr(5y)137.67%
Cap/Sales(3y)44.33%
Cap/Sales(5y)66.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.59%
EPS Next Y97.01%
EPS Next 2Y68.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.61%
Revenue growth 3Y-5.79%
Revenue growth 5Y10.44%
Sales Q2Q%-43.46%
Revenue Next Year13.04%
Revenue Next 2Y31.88%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y127.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y115.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.14%
OCF growth 3YN/A
OCF growth 5YN/A
PLANT ADVANCED TECHNOLOGIES / ALPAT.PA FAQ
Can you provide the ChartMill fundamental rating for PLANT ADVANCED TECHNOLOGIES?
ChartMill assigns a fundamental rating of 5 / 10 to ALPAT.PA.
Can you provide the valuation status for PLANT ADVANCED TECHNOLOGIES?
ChartMill assigns a valuation rating of 7 / 10 to PLANT ADVANCED TECHNOLOGIES (ALPAT.PA). This can be considered as Undervalued.
Can you provide the profitability details for PLANT ADVANCED TECHNOLOGIES?
PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) has a profitability rating of 6 / 10.
What is the financial health of PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) stock?
The financial health rating of PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) is 3 / 10.